ARTICLE | Company News
Ildong, TG Therapeutics deal
November 19, 2012 8:00 AM UTC
TG Therapeutics granted Ildong exclusive rights to develop and commercialize ublituximab in South Korea and Southeast Asia. TG Therapeutics will receive $2 million up front and is eligible for undiscl...